Strategic Partnerships PurpleSun has a history of forming partnerships with major health networks and industry groups (Hackensack Meridian Health, Northwell Health, HANYS, APIC). Leverage these relationships to open pilot programs and co-marketing opportunities with large hospital systems and associations.

Clinical Validation The company emphasizes best-in-class efficacy and clinical data for its FMUV technology. Use this to target procurement and infection prevention committees with evidence-backed ROI to justify adoption in ORs, ICUs, and long-term care facilities.

Expansion Readiness Existing deployments across hospitals, long-term care, and surgical centers indicate scalable deployment capabilities. Position PURPLESUN as a scalable solution for hospital network rollouts and multi-site infection control programs.

Public Market Potential Frequent press coverage and announcements around new systems (E300) and partnerships suggest growing market interest. Approach government agencies and large health systems for funded or grant-backed pilots leveraging FMUV Shadowless Delivery technology.

Affordability & ROI Revenue range and venture-backed status imply flexibility in pricing and a focus on cost savings from reduced infections. Craft value propositions around cost per disinfection, reduced HAI rates, and faster room turnover to appeal to finance and operations buyers.